In this regard, CAVIN1 and other caveolae-associated proteins have been described as markers of poor prognosis in pancreatic cancer (where they modulated caveolin-1 function (Liu et al, 2014)), glioblastoma (Pu et al, 2019), breast (Mercier and Lisanti, 2012), or rhabdomyopsarcoae (Faggi et al, 2015). Here, CAVIN1 is linked to familial pancreatic carcinoma.